Empower Advisory Group
PFE icon

Empower Advisory Group’s Pfizer PFE Stock Holding History

Empower Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116M Sell
4,830,581
-795,541
-14% -$20.8M 0.28% 68
2026
Q1 		$158M Buy
5,626,122
+482,503
+9% +$12.8M 0.41% 43
2025
Q4 		$128M Buy
5,143,619
+108,278
+2% +$2.73M 0.35% 50
2025
Q3 		$128M Buy
5,035,341
+187,106
+4% +$4.62M 0.36% 49
2025
Q2 		$118M Buy
4,848,235
+429,110
+10% +$10M 0.35% 52
2025
Q1 		$112M Buy
4,419,125
+566,442
+15% +$14.8M 0.37% 53
2024
Q4 		$102M Sell
3,852,683
-177,295
-4% -$4.81M 0.34% 59
2024
Q3 		$117M Buy
4,029,978
+153,573
+4% +$4.48M 0.39% 52
2024
Q2 		$108M Buy
3,876,405
+138,686
+4% +$3.82M 0.4% 52
2024
Q1 		$104M Buy
3,737,719
+868,644
+30% +$24.1M 0.39% 56
2023
Q4 		$82.6M Buy
2,869,075
+398,704
+16% +$12.1M 0.33% 70
2023
Q3 		$81.9M Sell
2,470,371
-68,476
-3% -$2.42M 0.36% 55
2023
Q2 		$93.1M Buy
2,538,847
+240,641
+10% +$9.37M 0.4% 51
2023
Q1 		$95M Buy
+2,298,206
New +$99.3M 0.43% 47

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Empower Advisory Group's PFE Position: Q2 2026 in Review

Empower Advisory Group reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $20.8M and leaving 4,830,581 shares worth $116M. The position accounts for 0.28% of the portfolio, ranked #68.

Empower Advisory Group first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $158M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Empower Advisory Group held 4,830,581 shares of Pfizer worth $116M as of Q2 2026.
  • Empower Advisory Group sold 795,541 Pfizer shares in Q2 2026, an estimated $20.8M.
  • Pfizer made up 0.28% of Empower Advisory Group's portfolio in Q2 2026, its #68 holding.
  • Empower Advisory Group first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
  • Empower Advisory Group's Pfizer position peaked at $158M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.